Literature DB >> 22052431

Nuclear medicine, scientific publishing and the era of cost containment.

Ignasi Carrió.   

Abstract

Mesh：

Year:  2011        PMID： 22052431     DOI： 10.1007/s00259-011-1982-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  Delivering affordable cancer care in high-income countries.

Authors:  Richard Sullivan; Jeffrey Peppercorn; Karol Sikora; John Zalcberg; Neal J Meropol; Eitan Amir; David Khayat; Peter Boyle; Philippe Autier; Ian F Tannock; Tito Fojo; Jim Siderov; Steve Williamson; Silvia Camporesi; J Gordon McVie; Arnie D Purushotham; Peter Naredi; Alexander Eggermont; Murray F Brennan; Michael L Steinberg; Mark De Ridder; Susan A McCloskey; Dirk Verellen; Terence Roberts; Guy Storme; Rodney J Hicks; Peter J Ell; Bradford R Hirsch; David P Carbone; Kevin A Schulman; Paul Catchpole; David Taylor; Jan Geissler; Nancy G Brinker; David Meltzer; David Kerr; Matti Aapro
Journal:  Lancet Oncol       Date:  2011-09       Impact factor: 41.316

2.  Matched pairs for radionuclide-based imaging and therapy.

Authors:  Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05       Impact factor: 9.236

3.  Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.

Authors:  Ingrid Dijkgraaf; John A W Kruijtzer; Shuang Liu; Annemieke C Soede; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-15       Impact factor: 9.236

4.  A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue.

Authors:  Vladimir Tolmachev; Irina Velikyan; Mattias Sandström; Anna Orlova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-04       Impact factor: 9.236

5.  Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Authors:  Giampiero Giovacchini; Maria Picchio; Elisa Coradeschi; Valentino Bettinardi; Luigi Gianolli; Vincenzo Scattoni; Cesare Cozzarini; Nadia Di Muzio; Patrizio Rigatti; Ferruccio Fazio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

6.  Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody.

Authors:  Weibo Cai; Kai Chen; Lina He; Qizhen Cao; Albert Koong; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-30       Impact factor: 10.057
  6 in total
  3 in total

1.  Nuclear medicine, scientific publishing and the era of cost containment: what factors hold the key?

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-14       Impact factor: 9.236

2.  Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

Authors:  Valentina Ambrosini; Davide Campana; Cristina Nanni; Silvia Cambioli; Paola Tomassetti; Domenico Rubello; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-15       Impact factor: 9.236

3.  Asia Oceania Journal of Nuclear Medicine & Biology; A big step forward to advance scientific publication & cooperation in the region.

Authors:  Seyed Rasoul Zakavi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.